Sofinnova Venture Partners X, L.P.'s Net Worth
$165 Million
Who is Sofinnova Venture Partners X, L.P.?
Sofinnova Venture Partners X, L.P. has an estimated net worth of $165 Million. This is based on reported shares across multiple companies, which include CinCor Pharma, Inc., Vera Therapeutics, Inc., Aerovate Therapeutics, Inc., Inozyme Pharma, Inc., Bolt Biotherapeutics, Inc., and Akouos, Inc..
SEC CIK
Sofinnova Venture Partners X, L.P.'s CIK is 0001680200
Past Insider Trading and Trends
2021 was Sofinnova Venture Partners X, L.P.'s most active year for acquiring shares with 7 total transactions. Sofinnova Venture Partners X, L.P.'s most active month to acquire stocks was the month of January. 2021 was Sofinnova Venture Partners X, L.P.'s most active year for disposing of shares, totalling 4 transactions. Sofinnova Venture Partners X, L.P.'s most active month to dispose stocks was the month of January. 2022 saw Sofinnova Venture Partners X, L.P. paying a total of $24,199,990.00 for 6,340,615 shares, this is the most they've acquired in one year. In 2022 Sofinnova Venture Partners X, L.P. cashed out on 17,852,428 shares for a total of $85,920.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vera Therapeutics, Inc. (VERA) Snapshot price: $37.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.98% | 285.71K |
$7.00 | $1,999,998.00 | 3.47M |
Feb 6
| |||
Form 4
| +9.15% | 266.67K |
$15.00 | $3,999,990.00 | 3.18M |
Feb 10
| |||
Form 4
|
∞
| 2.91M |
$11.00 |
—
| 2.91M |
May 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $20.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.76M |
$14.00 |
—
| 3.76M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inozyme Pharma, Inc. (INZY) Snapshot price: $5.365
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.03M |
$16.00 |
—
| 2.03M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akouos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.52M |
$17.00 |
—
| 1.52M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.11M |
$14.32 | -$85,920.00 |
0
|
Nov 28 - Feb 24
| |||
Form 4
| +8.97% | 500K |
$30.00 | $15,000,000.00 | 6.07M |
Aug 11
| |||
Form 4
|
∞
| 5.57M |
$16.00 |
—
| 5.57M |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||